A new type of cancer drug designed to unleash the immune system is revolutionizing treatment for advanced melanoma, lung cancer and other malignancies. But some patients who initially respond to the therapy relapse, and researchers are anxious to figure out how and why the delayed resistance occurs.
Democracy Dies in Darkness
Here are some ways cancer can thwart the new immunotherapy drugs
July 13, 2016 at 5:00 p.m. EDT